Self‐efficacy · COPD
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Behaviour change: smoking cessation · COPD
1 finding from 1 review
Functional capacity · COPD
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Anxiety and depression · COPD
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Intervention not reported
Health‐related quality of life (respiratory specific) St George's Respiratory Questionnaire (SGRQ; total score) Scale from 0‐100 Lower value post intervention is favourable, indicating improvement in health‐related quality of life · people with stable COPD
1 finding from 1 review
Intervention not reported
Health‐related quality of life (generic) SF‐36 (Physical Component Summary (PCS) score) Scale from 0‐100 Higher value post intervention is favourable, indicating improvement in health‐related quality of life · people with stable COPD
1 finding from 1 review
Intervention not reported
Health‐related quality of life (generic) SF‐36 (Mental Component Sumary (MCS) score) Scale from 0‐100 Higher value post intervention is favourable, indicating improvement in health‐related quality of life · people with stable COPD
1 finding from 1 review
Intervention not reported
Dyspnoea Basal Dyspnea Index (BDI) (score) Scale from 0‐12 Higher value post intervention is favourable, indicating improvement in dyspnoea · people with stable COPD
1 finding from 1 review
Prolonged abstinence at longest · smokers with COPD
Behavioural treatment probably leads to higher prolonged abstinence at longest compared with no treatment or usual care (moderate certainty).
1 finding from 1 review
Prolonged abstinence at longest · smokers with COPD
1 finding from 1 review
Point prevalence abstinence at longest · smokers with COPD
Pharmacological treatment probably leads to higher point prevalence abstinence at longest compared with a different pharmacological treatment (moderate certainty).
1 finding from 1 review
Prolonged abstinence at longest · smokers with COPD
1 finding from 1 review
Point prevalence abstinence at longest · smokers with COPD
1 finding from 1 review
Point prevalence abstinence at longest · smokers with COPD
1 finding from 1 review
Prolonged abstinence at longest · smokers with COPD
1 finding from 1 review
Point prevalence abstinence at longest · smokers with COPD
1 finding from 1 review
Prolonged abstinence at longest · smokers with COPD
Pharmacological treatment leads to higher prolonged abstinence at longest compared with placebo (high certainty).
5 findings from 1 review
RR 2.53 [1.83, 3.5]
4 studies · 1429 participants
High
RR 2.6 [1.29, 5.24]
1 study · 370 participants
High
RR 2.03 [1.26, 3.28]
2 studies · 503 participants
Moderate
Show 2 more findings
FEV1 · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Quality of life: number of participants with clinically significant improvement (≥ 4 units) in SGRQ total score · patients with chronic obstructive pulmonary disease
Indacaterol leads to higher number of participants with a clinically significant improvement in… compared with placebo (high certainty).
1 finding from 1 review
Improvement in symptoms: number of participants with clinically significant improvement: using TDI focal score (≥ 1 unit) · patients with chronic obstructive pulmonary disease
Indacaterol leads to higher number of participants with clinically significant improvement in… compared with placebo (high certainty).
1 finding from 1 review